Analyst Research Report Snapshot


ACADIA Pharmaceuticals Inc.




MarketLine (a Datamonitor Company)


22 Jan 2014





Companies referenced:


Available for Immediate Download

ACADIA Pharmaceuticals Inc. Company Profile is the essential source for top-level company data and information. ACADIA Pharmaceuticals Inc. Company Profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. ACADIA Pharmaceuticals (ACADIA) is a biopharmaceutical company focused on developing drugs for the treatment of neurological and related central nervous system disorders. ACADIA's product pipeline includes pimavanserin, a drug in phase III development stage used for the treatment of Parkinson’s disease psychosis (PDP). In addition, ACADIA also conducts clinical-stage programs for chronic pain and glaucoma in collaboration with Allergan. The company operates in the US and Denmark. It is headquartered in San Diego, California, and employs around 26 people. The company recorded revenues of $4.9 million in the fiscal year ended December 2012, as compared to the revenues of $2.1 million in 2011. The company's operating loss was $20.9 million in fiscal 2012, as compared to an operating loss of $22.9 million in 2011. Its net loss was $20.8 million in fiscal 2012, as compared to the net loss of $22.8 million in 2011. Scope of the Report - Provides all the crucial information on ACADIA Pharmaceuticals Inc. required for business and competitor intelligence needs -Data is supplemented with details on ACADIA Pharmaceuticals Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from ACADIA Pharmaceuticals Inc. Reasons to Purchase - Support sales activities by understanding your customers’ businesses better - Understand prospective partners and suppliers - Keep fully up to date on your competitors’ business structure, strategy and prospects - Obtain the most up to date company information available

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.